ASXL1 Gene Mutation clinical trials at UCLA
1 research study open to eligible people
open to all eligible people
A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).
Los Angeles, California
Our lead scientists for ASXL1 Gene Mutation research studies include Bianca Russell, MD.